Search for: "Janssen Research "
Results 101 - 120
of 199
Sorted by Relevance
|
Sort by Date
13 Dec 2023, 6:03 am
The conference, which is part of a larger research project, takes the leading German decision on the question as a starting point to discuss if and to what extent its highly restrictive approach is still tenable. [read post]
10 Jun 2015, 11:51 am
This news report from Medscape, "Four Diabetic Ketoacidosis Episodes Triple Risk of Early Death", provides a summary of and some contextual information about this important new medical study: In a cohort of adult patients with type 1 diabetes who were hospitalized with diabetic ketoacidosis (DKA) in Edinburgh, Scotland, almost all patients survived the hospitalization, but they had an increased risk of early death, new research shows. [read post]
7 Feb 2017, 11:58 am
These fees paid did not include payments for research. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) … [read post]
2 Feb 2017, 7:42 am
Thousands of lawsuits have already been filed against Xarelto manufacturer Janssen Pharmaceuticals. [read post]
10 Dec 2020, 1:45 pm
Each year, Janssen Pharmaceuticals sells more than $150 million dollars’ worth of Elmiron to millions of patients in the United States. [read post]
5 Jun 2012, 2:24 am
Minnesota Legal Studies Research Paper No. 12-20. [read post]
16 Apr 2012, 8:26 pm
Nevertheless, Janssen Pharmaceuticals, Inc. [read post]
18 Dec 2017, 12:11 pm
Pre-market research conducted by the Johnson & Johnson subsidiary Janssen revealed the tendency of the drug to cause gynecomastia, yet warnings on the drug’s labels greatly understate the potential risk of breast development in males who take the medication. [read post]
1 Dec 2010, 12:15 am
Apotex, Inc (Patently-O) Simcor (Niacin/Simvastatin) – US: Impax Laboratories confirms patent challenge relating to Simcor extended-release tablets (SmartBrief) Taxotere (Docetaxel) – EU: Actavis launches Docetaxel single vial on patent expiry in major European markets (GenericsWeb) Temodar (Temozolide) – US: Cancer Research Technology files patent infringement suit against Accord following Para IV certification filing (Patent Docs) Tri-Cyclen Lo (Norgestimate/ethinyl… [read post]
19 May 2010, 8:58 am
"In January, the FDA and other U.S. health agencies pledged $30 million toward short-and long-term research aimed at clarifying the health effects of the chemical. [read post]
18 Dec 2017, 12:11 pm
Pre-market research conducted by the Johnson & Johnson subsidiary Janssen revealed the tendency of the drug to cause gynecomastia, yet warnings on the drug’s labels greatly understate the potential risk of breast development in males who take the medication. [read post]
10 Aug 2009, 10:06 pm
Plaintiffs for Levaquin lawsuits claim the manufacturer, Ortho-McNeil-Janssen Pharmaceuticals, failed to research its product adequately prior to bringing Levaquin to market in 1996 and failed to warn about adverse effects to the tendon. [read post]
28 Mar 2012, 2:59 am
""FDA has a responsibility to protect the public's health and one step they must take to fulfill their mission is banning BPA as a food additive," said Sarah Janssen, an NRDC scientist. [read post]
18 Jul 2013, 10:45 am
Ortho-McNeil-Janssen Pharmaceuticals, 2013 WL 3480286 (Pa. [read post]
4 May 2017, 1:00 am
The clinical research of pharmaceutical polymorphs commenced in 1950s internationally though, it was until in mid-1990s did Chinese research institutions and pharmaceutical enterprises recognize the importance of pharmaceutical polymorphs after the first awareness of the significant efficacy difference between imported nimodipine and the homemade one. [read post]
27 Jul 2020, 5:14 am
Current research indicates that PPS maculopathy appears to be limited to patients taking Elmiron and has not been seen in interstitial cystitis patients receiving other types of medication or treatment. [read post]
27 Jul 2020, 5:14 am
Current research indicates that PPS maculopathy appears to be limited to patients taking Elmiron and has not been seen in interstitial cystitis patients receiving other types of medication or treatment. [read post]
21 Sep 2020, 10:51 am
All content added will be cleaned, normalized and enriched by LIDI and its supporters to accelerate the research and development efforts of members, collaborators and the supplying courts and tribunals. [read post]
2 Nov 2011, 2:00 am
Research & Diagnostic Systems (Pharma Patents) US: Roundup Ready® Soybeans: Patent exhaustion in self-replicating biotechnologies (IP Osgoode) US: FDA continues efforts to expand power over intrastate commerce (FDA Law Blog) US: Defendants’ persistence in pursuing “baseless inequitable conduct claim” justified award of attorneys’ fees to plaintiff: Pfizer et. al v. [read post]
